China Healthwise Holdings Limited
China Healthwise Holdings Limited (0348.HK) Stock Competitors & Peer Comparison
See (0348.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0348.HK | HK$0.09 | +0.00% | 70.9M | -9.20 | -HK$0.01 | N/A |
| 0241.HK | HK$4.72 | +0.64% | 75.1B | 33.29 | HK$0.14 | N/A |
| 3613.HK | HK$7.74 | +1.98% | 6.5B | 16.51 | HK$0.47 | +4.51% |
| 1345.HK | HK$2.21 | -3.49% | 2.7B | 23.00 | HK$0.10 | +5.22% |
| 1110.HK | HK$0.49 | -3.00% | 294.8M | 50.00 | HK$0.01 | +6.60% |
| 3390.HK | HK$0.27 | -1.85% | 245.9M | -6.87 | -HK$0.04 | N/A |
| 0574.HK | HK$0.04 | -11.36% | 59M | -0.80 | -HK$0.05 | N/A |
| 2211.HK | HK$0.57 | +9.62% | 45.3M | -1.59 | -HK$0.32 | N/A |
Stock Comparison
0348.HK vs 0241.HK Comparison April 2026
0348.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0348.HK stands at 70.9M. In comparison, 0241.HK has a market cap of 75.1B. Regarding current trading prices, 0348.HK is priced at HK$0.09, while 0241.HK trades at HK$4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0348.HK currently has a P/E ratio of -9.20, whereas 0241.HK's P/E ratio is 33.29. In terms of profitability, 0348.HK's ROE is +0.25%, compared to 0241.HK's ROE of +0.14%. Regarding short-term risk, 0348.HK is less volatile compared to 0241.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0348.HK.Check 0241.HK's competition here